JMP Securities Reiterates “Market Outperform” Rating for Two Harbors Investment (NYSE:TWO)
Two Harbors Investment (NYSE:TWO – Get Free Report)‘s stock had its “market outperform” rating reissued by equities research analysts at JMP Securities in a note issued to investors on Thursday,Benzinga reports.
JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...
JMP Securities adjusted its outlook on Twilio (NYSE:TWLO) shares, raising the price target to $165 from the previous $110 ...
JMP Securities raised the firm’s price target on HealthEquity (HQY) to $120 from $107 and keeps an Outperform rating on the shares amid a ...
JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...
On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...
JMP Securities initiated coverage of Context Therapeutics (CNTX) with an Outperform rating and $4 price target Context is a $97.8M market cap clinical-stage biotechnology company focused on ...
Investors were advised to focus on the durability of ADR and RevPAR, as well as management's expectations for the industry in 2025. According to InvestingPro's comprehensive analysis, BKNG ...
JMP Securities analyst Andrew Boone maintained a Buy rating on Meta Platforms (META – Research Report) today and set a price target of $750.00.
JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback